Zura Bio Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Zura Bio Ltd
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
/ 
Frequently asked questions
To buy Zura Bio Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Zura Bio Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Zura Bio Ltd is ZURA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Zura Bio Ltd has its primary listing on NASDAQ (Small cap). You can trade Zura Bio Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Zura Bio Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Zura Bio Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Zura Bio Ltd.